Scarica l'app Stockscreener
69.13
0.85%
0.58
Dopo l'orario di chiusura:
68.76
-0.37
-0.54%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$68.55
Aprire:
$68.96
Volume 24 ore:
11.66M
Relative Volume:
0.82
Capitalizzazione di mercato:
$102.58B
Reddito:
$20.08B
Utile/perdita netta:
$2.89B
Rapporto P/E:
35.65
EPS:
1.9391
Flusso di cassa netto:
$3.66B
1 W Prestazione:
-3.11%
1M Prestazione:
-7.49%
6M Prestazione:
-32.69%
1 anno Prestazione:
-27.51%
Intervallo 1D:
$68.41
$69.59
Intervallo di 1 settimana:
$67.56
$72.37
Portata 52W:
$67.56
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Nome
Boston Scientific Corp
Settore
Industria
Telefono
508-683-4000
Indirizzo
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
69.13 | 102.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
ABT
Abbott Laboratories
|
108.03 | 187.72B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
336.77 | 128.88B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.14 | 111.88B | 35.48B | 4.64B | 5.41B | 3.582 |
|
EW
Edwards Lifesciences Corp
|
81.81 | 47.52B | 6.07B | 1.06B | 1.34B | 1.8063 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-03 | Downgrade | Erste Group | Buy → Hold |
| 2025-09-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-04-16 | Aggiornamento | Needham | Hold → Buy |
| 2025-01-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Downgrade | Needham | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-02-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-20 | Ripresa | Citigroup | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-27 | Aggiornamento | Needham | Hold → Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-05-26 | Downgrade | Needham | Buy → Hold |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Buy |
| 2019-12-30 | Reiterato | Cowen | Outperform |
| 2019-12-19 | Downgrade | Needham | Strong Buy → Buy |
| 2019-09-05 | Ripresa | JP Morgan | Overweight |
| 2019-09-03 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-10-02 | Reiterato | Morgan Stanley | Overweight |
| 2018-09-07 | Reiterato | Needham | Strong Buy |
| 2018-09-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-07-06 | Reiterato | Needham | Strong Buy |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-04-26 | Reiterato | Needham | Strong Buy |
Mostra tutto
Boston Scientific Corp Borsa (BSX) Ultime notizie
INVESTOR DEADLINE: Snowflake Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law - GlobeNewswire Inc.
Why Boston Scientific (BSX) Dipped More Than Broader Market Today - Yahoo Finance
INVESTOR NOTICE: Boston Scientific Corporation Investors with Su - GuruFocus
Boston Scientific stock hits 52-week low at 68.19 USD - Investing.com
INVESTOR NOTICE: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
BSX INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 – Company AnnouncementFT.com - Financial Times
Boston Scientific Corp (NYSE:BSX): A GARP Stock with Strong Growth and Reasonable Valuation - ChartMill
Franklin Resources Inc. Sells 708,747 Shares of Boston Scientific Corporation $BSX - MarketBeat
Steve Mandel's Boston Scientific Corp(BSX) Holding History - GuruFocus
First Trust Advisors LP Boosts Stock Position in Boston Scientific Corporation $BSX - MarketBeat
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit - Financial Times
Deadline Approaching: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith - ChartMill
Kepler Cheuvreux Suisse SA Buys Shares of 276,126 Boston Scientific Corporation $BSX - MarketBeat
Mackenzie Financial Corp Increases Position in Boston Scientific Corporation $BSX - MarketBeat
Magnetar Financial LLC Has $6.78 Million Holdings in Boston Scientific Corporation $BSX - MarketBeat
Citigroup Adjusts Price Target on Boston Scientific to $94 From $102, Maintains Buy Rating - marketscreener.com
Baird Adjusts Price Target on Boston Scientific to $95 From $101, Maintains Outperform Rating - marketscreener.com
Capital Research Global Investors Acquires 23,940 Shares of Boston Scientific Corporation $BSX - MarketBeat
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
INVESTOR ALERT: Boston Scientific Corporation Investors - GlobeNewswire
BSX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
BSX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 (2026-03-10) - Seeking Alpha
Important Notice to Long-Term Shareholders of Boston - GlobeNewswire
Class Action Filed Against Boston Scientific Corporation (BSX)May 4, 2026 Deadline to JoinContact The Gross Law Firm - marketscreener.com
Richard Bernstein Advisors LLC Sells 51,186 Shares of Boston Scientific Corporation $BSX - MarketBeat
Capital World Investors Has $2.60 Billion Holdings in Boston Scientific Corporation $BSX - MarketBeat
2026-03-10 | BSX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NYSE:BSX | Press Release - Stockhouse
Swiss National Bank Has $416.36 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Stake Lowered by Schroder Investment Management Group - MarketBeat
Fieldview Capital Management LLC Invests $5.34 Million in Boston Scientific Corporation $BSX - MarketBeat
BSX Investors Have Opportunity to Join Boston Scientific Corporation Fraud Investigation with the Schall Law Firm - ChartMill
BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - TMX Newsfile
A Look At Boston Scientific (BSX) Valuation After Class Actions And Electrophysiology Guidance Cuts - simplywall.st
Orion Porfolio Solutions LLC Boosts Position in Boston Scientific Corporation $BSX - MarketBeat
Dynamic Technology Lab Private Ltd Purchases Shares of 24,096 Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Bought by Aptus Capital Advisors LLC - MarketBeat
Boston Scientific Recall And Lawsuits Test Earnings Power And Capital Plans - Yahoo Finance
Is Boston Scientific (BSX) Balancing Buybacks and Litigation or Masking Deeper Electrophysiology Risks? - Yahoo Finance
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Boston Scientific Faces Class Action Lawsuit - Intellectia AI
Boston Scientific Recall And Lawsuits Weigh On Outlook And Valuation Gap - simplywall.st
Boston Scientific Investor Sues Over Growth Projections - Law360
Boston Scientific Overpromised Segment’s Performance, Suit Says - Bloomberg Law News
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
BSX Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Boston Scientific Corporation – Company AnnouncementFT.com - Financial Times
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX) - marketscreener.com
Rosen Law Firm Urges Boston Scientific Corporation (NYSE: BSX) Stockholders to Contact the Firm for Information About Their Rights - ChartMill
Boston Scientific’s ENTRUST Registry Targets Real-World Edge in Carotid Stroke Prevention - TipRanks
Why Is Boston Scientific (BSX) Down 6% Since Last Earnings Report? - finance.yahoo.com
Here's Why Boston Scientific (BSX) is a Strong Growth Stock - Yahoo Finance
Boston Scientific to host investor event at the 75th Annual Scientific Session of the American College of Cardiology - Finviz
Boston Scientific Corp Azioni (BSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.27%
0.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):